Filing Details
- Accession Number:
- 0001209191-15-079159
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-09 17:38:19
- Reporting Period:
- 2015-11-05
- Filing Date:
- 2015-11-09
- Accepted Time:
- 2015-11-09 17:38:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557290 | A Stuart Arbuckle | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp\Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-11-05 | 5,664 | $45.11 | 110,412 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-11-05 | 600 | $77.31 | 111,012 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-05 | 2,444 | $122.46 | 108,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-05 | 2,400 | $123.04 | 106,168 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-05 | 1,220 | $124.59 | 104,948 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-05 | 200 | $125.17 | 104,748 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-11-05 | 5,664 | $0.00 | 5,664 | $45.11 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-11-05 | 600 | $0.00 | 600 | $77.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,320 | 2023-02-04 | No | 4 | M | Direct | |
| 41,900 | 2024-02-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 140 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
- Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $122.46 (range $121.84 to $122.82).
- Open market sales reported on this line occurred at a weighted average price of $123.04 (range $122.84 to $123.60).
- Open market sales reported on this line occurred at a weighted average price of $124.59 (range $124.08 to $124.99).
- Open market sales reported on this line occurred at a weighted average price of $125.17 (range $125.13 to $125.21).
- The option vests in 16 quarterly installments from 02/05/2013.
- The option vests in 16 quarterly installments from 02/05/2014.
Billionaire Hedge Funds
